Publications by authors named "M P Stoppelli"

Glioblastoma (GBM) is the most aggressive type of brain tumor, characterized by poor outcome and limited therapeutic options. During tumor progression, GBM may undergo the process of vasculogenic mimicry (VM), consisting of the formation of vascular-like structures which further promote tumor aggressiveness and malignancy. The resulting resistance to anti-angiogenetic therapies urges the identification of new compounds targeting VM.

View Article and Find Full Text PDF

Multiple oncogenic alterations contribute to breast cancer development. Metabolic reprogramming, deeply contributing to tumor microenvironment (TME) education, is now widely recognized as a hallmark of cancer. The reverse Warburg effect induces cancer-associated fibroblasts (CAFs) to produce and secrete L-lactate, enhancing malignant characteristics such as neoangiogenesis, metastatic dissemination, and treatment resistance.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma (GBM) is one of the most aggressive human cancers, and there is a critical need for new treatment methods.
  • Research on the cyclic decapeptide uPAcyclin shows it specifically binds to GBM cells and hinders their movement and ability to invade surrounding tissues without affecting their growth.
  • uPAcyclin significantly reduces the formation of vascular-like structures in GBM cells, indicating its potential as a targeted therapy to prevent new blood vessel formation in treating GBM.
View Article and Find Full Text PDF

Tumor growth and metastasis strongly rely on cell-cell communication. One of the mechanisms by which tumor cells communicate involves the release and uptake of lipid membrane encapsulated particles full of bioactive molecules, called extracellular vesicles (EVs). EV exchange between cancer cells may induce phenotype changes in the recipient cells.

View Article and Find Full Text PDF